Vitamin D stimulates apoptosis in gastric cancer cells in synergy with trichostatin A /sodium butyrate-induced and 5-aza-2'-deoxycytidine-induced PTEN upregulation. 2010

Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
The Institute of Genetics and Cytology, Northeast Normal University, Changchun, China.

Previous studies have shown an anticancer effect of vitamin D, but the mechanisms underlying this action have not been fully explored. Here we show that 1,25-dihydroxyvitamin D3 (VD3, the active form of vitamin D) significantly promoted apoptosis in the undifferentiated gastric cancer cell line HGC-27, and this was accompanied by a concurrent increase in phosphatase and tensin homolog deleted on chromosome 10 (PTEN) expression on VD3 treatment. In contrast, knockdown of PTEN expression by stable transfection of PTEN small interfering RNA greatly decreased the apoptosis rate. We further demonstrated that VD3 induced PTEN expression through vitamin D receptor. In addition, our evidence showed that vitamin D receptor, Egr-1 and p300 induced PTEN expression in a synergistic fashion. Furthermore, we found that the histone deacetylase inhibitors trichostatin A and sodium butyrate and the methylation inhibitor 5-aza-2'-deoxycytidine played important roles in vitamin D-induced apoptosis through PTEN upregulation. The data presented in this article suggest potential benefits of vitamin D in gastric cancer therapies in association with the use of trichostatin A/sodium butyrate and 5-aza-2'-deoxycytidine.

UI MeSH Term Description Entries
D011401 Promoter Regions, Genetic DNA sequences which are recognized (directly or indirectly) and bound by a DNA-dependent RNA polymerase during the initiation of transcription. Highly conserved sequences within the promoter include the Pribnow box in bacteria and the TATA BOX in eukaryotes. rRNA Promoter,Early Promoters, Genetic,Late Promoters, Genetic,Middle Promoters, Genetic,Promoter Regions,Promoter, Genetic,Promotor Regions,Promotor, Genetic,Pseudopromoter, Genetic,Early Promoter, Genetic,Genetic Late Promoter,Genetic Middle Promoters,Genetic Promoter,Genetic Promoter Region,Genetic Promoter Regions,Genetic Promoters,Genetic Promotor,Genetic Promotors,Genetic Pseudopromoter,Genetic Pseudopromoters,Late Promoter, Genetic,Middle Promoter, Genetic,Promoter Region,Promoter Region, Genetic,Promoter, Genetic Early,Promoter, rRNA,Promoters, Genetic,Promoters, Genetic Middle,Promoters, rRNA,Promotor Region,Promotors, Genetic,Pseudopromoters, Genetic,Region, Genetic Promoter,Region, Promoter,Region, Promotor,Regions, Genetic Promoter,Regions, Promoter,Regions, Promotor,rRNA Promoters
D002087 Butyrates Derivatives of BUTYRIC ACID. Included under this heading are a broad variety of acid forms, salts, esters, and amides that contain the carboxypropane structure. Butyrate,n-Butyrate,Butanoic Acids,Butyric Acids,Acids, Butanoic,Acids, Butyric,n Butyrate
D006657 Histones Small chromosomal proteins (approx 12-20 kD) possessing an open, unfolded structure and attached to the DNA in cell nuclei by ionic linkages. Classification into the various types (designated histone I, histone II, etc.) is based on the relative amounts of arginine and lysine in each. Histone,Histone H1,Histone H1(s),Histone H2a,Histone H2b,Histone H3,Histone H3.3,Histone H4,Histone H5,Histone H7
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006877 Hydroxamic Acids A class of weak acids with the general formula R-CONHOH. Hydroxamic Acid,Acid, Hydroxamic,Acids, Hydroxamic
D000077209 Decitabine An azacitidine derivative and antineoplastic antimetabolite. It inhibits DNA methyltransferase to re-activate silent genes, limiting METASTASIS and NEOPLASM DRUG RESISTANCE. Decitabine is used in the treatment of MYELODISPLASTIC SYNDROMES, and ACUTE MYELOID LEUKEMIA. 2'-Deoxy-5-azacytidine,5-Aza-2'-deoxycytidine,5-AzadC,5-Azadeoxycytidine,5-Deoxyazacytidine,5AzadC,AzadC Compound,Dacogen,Decitabine Mesylate,NSC 127716,NSC-127716,2' Deoxy 5 azacytidine,5 Aza 2' deoxycytidine,5 Azadeoxycytidine,5 Deoxyazacytidine,Compound, AzadC,Mesylate, Decitabine,NSC127716
D000107 Acetylation Formation of an acetyl derivative. (Stedman, 25th ed) Acetylations
D001374 Azacitidine A pyrimidine analogue that inhibits DNA methyltransferase, impairing DNA methylation. It is also an antimetabolite of cytidine, incorporated primarily into RNA. Azacytidine has been used as an antineoplastic agent. Azacytidine,5-Azacytidine,NSC-102816,Vidaza,5 Azacytidine,NSC 102816,NSC102816
D013274 Stomach Neoplasms Tumors or cancer of the STOMACH. Cancer of Stomach,Gastric Cancer,Gastric Neoplasms,Stomach Cancer,Cancer of the Stomach,Gastric Cancer, Familial Diffuse,Neoplasms, Gastric,Neoplasms, Stomach,Cancer, Gastric,Cancer, Stomach,Cancers, Gastric,Cancers, Stomach,Gastric Cancers,Gastric Neoplasm,Neoplasm, Gastric,Neoplasm, Stomach,Stomach Cancers,Stomach Neoplasm
D014807 Vitamin D A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE.

Related Publications

Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
November 2002, Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
February 2013, British journal of cancer,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
November 2017, Plant signaling & behavior,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
September 2009, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
October 2016, Oncology reports,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
January 2008, Cancer research,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
August 2011, Clinical epigenetics,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
August 2014, Molecules and cells,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
September 2004, Oncogene,
Lina Pan, and Ammar F Matloob, and Juan Du, and Hong Pan, and Zhixiong Dong, and Jing Zhao, and Yu Feng, and Yun Zhong, and Baiqu Huang, and Jun Lu
September 2009, International journal of cancer,
Copied contents to your clipboard!